Drawing for EMPIRICO

USPTO serial 88246067

EMPIRICO

Reviewed by CopyMark Law Group

Reg. 6109523Status 701Renewal
Filing date
Status date
Registration date
Jul 21, 2020
Examiner
MUCHA, JOHN EVAN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with EMPIRICO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chelsea E. Carbone

Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research in connection with human genetics and programmable biology; pharmaceutical research in the fields of angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry; pharmaceutical research in the fields of pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical research in the field of treatment of infectious, deficiency, hereditary, and physiological diseases; medical research in connection with various diseases and disorders, including eosinophilic diseases, asthma, CRS, and allergic rhinitis, autoimmune diseases, including psoriasis, vitiligo, and lichen planus, ocular diseases, including intraocular pressure and glaucoma, and atopic dermatitisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Nov 29, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Nov 29, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 29, 2025ES8RTEAS SECTION 8 RECEIVED—
Jul 21, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 21, 2020R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jun 17, 2020PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2020ALIEASSIGNED TO LIE—
Jun 2, 2020ALIEASSIGNED TO LIE—
May 28, 2020AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
May 27, 2020CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
May 27, 2020IUAAUSE AMENDMENT ACCEPTED—
Apr 28, 2020AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Apr 28, 2020DPCCDIVISIONAL PROCESSING COMPLETE—
Apr 28, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 7, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2020IUAFUSE AMENDMENT FILED—
Apr 3, 2020DRRRDIVISIONAL REQUEST RECEIVED—
Apr 3, 2020EAAUTEAS AMENDMENT OF USE RECEIVED—
Apr 3, 2020ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 8, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2019DOCKASSIGNED TO EXAMINER—
Jan 23, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 3, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance